Schedule 13G ownership disclosure
Processa Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74275C106
Event date: 2018-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-092086
- Form type
- SC 13G
- Filer
- CONCERT PHARMACEUTICALS, INC.
- CIK
- CIK 1367920
- Filed
- Mar 22, 2018
- Reporting period
- Mar 19, 2018
- Description
- Schedule 13G beneficial ownership